Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2023-08-04 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
112年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings by insiders and directors of the company 景岳生物科技股份有限公司. It lists the number of shares held, pledged shares, and related percentages for various board members and executives. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of document corresponds to a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 2317 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-08-04 Chinese
112年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with zero balances and limits. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory certifications, and no mention of report attachments or presentations. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. The document length is very short (601 characters), and it is not an announcement of a report publication but a direct disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2023-07-10 Chinese
112年6月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief summary table of monthly and cumulative revenue figures for a company named 景岳, with explanations about accounting standards and reporting practices. It contains no detailed financial statements, no management discussion, no audit opinions, no legal or governance information, and no announcements of meetings or votes. The length is only 766 characters, indicating it is a short summary rather than a full report. It does not announce a report publication or provide a link to a full report, so it is not a Report Publication Announcement (RPA). The content fits best as a Fund Information / Factsheet (FS) because it provides a concise snapshot of key financial data (revenue) and related notes. Therefore, the classification is FS with high confidence.
2023-07-10 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (景岳生物科技股份有限公司) regarding the commitments made when applying for stock listing transfer and the subsequent execution status as of the second quarter of 2023. It references compliance with Taiwan Stock Exchange regulations and details about auditor commitments and financial reporting. The document is short (842 characters) and primarily serves as a regulatory disclosure about compliance and status updates rather than a full financial report or detailed audit report. It does not contain actual financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-05 Chinese
112年06月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, independent directors, general manager, and financial department heads. It lists share quantities held, changes in holdings, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of a full financial report, earnings release, or regulatory certification. The document is a report of personal share transactions by company directors and executives (insider trades). Therefore, it fits the category 'Director's Dealing' (DIRS). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification.
2023-07-04 Chinese
112年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors and senior management. It lists the number of shares held, pledged shares, and related percentages. The content focuses on insider shareholdings and pledging status rather than financial results, management changes, or meeting materials. This type of disclosure aligns with the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document is relatively short (2317 characters) and does not mention any report attachments or certifications, so it is not a report publication announcement or regulatory filing. Therefore, the best classification is DIRS with high confidence.
2023-07-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.